Cryptococcosis Market

Cryptococcosis Market - Global Industry
Analysis, Size, Share, Growth, Trends
and Forecast 2016 - 2024
The highly fragmented global cryptococcosis market is being pioneered
by only a handful of players based in developed regions of the world.
Pfizer, Inc., Valeant Pharmaceuticals, Inc., Bristol-Myers Squibb
Company, and Janssen Biotech, Inc. had collectively held a share of
41% in the global cryptococcosis market in terms of value, for 2015.
Their dominance in the market was marked by factors such as operating
stronghold in developed economies where the demand and awareness
are high, better brand name recognition, and higher investments in
research and development.
One of the key factors driving the global cryptococcosis market is the
increasing incidence of cryptococcosis infections across the world. The
number of patients suffering from cryptococcosis has been found to be
on the rise at a faster rate than previously thought. The patients suffering
from the fungal infection are found to be in high numbers among HIV
positive patients.
Consequently, the growing number of HIV patients is also spurring the
demand for advanced and effective treatment for the disease. Rising
initiatives by government and non-government organizations is also
putting the pipeline development in the global cryptococcosis market on
the fast track in many countries, especially in developed ones.

However, the global cryptococcosis market is currently being affected
by restraining factors such as the increased mortality among
cryptococcosis infected patients, which reduces the overall scope of
testing and diagnostics, and the imminent patent expiry of key drugs
which will result in the large scale entry of cheaper generics.
Browse Full Research Report on Cryptococcosis Market:
http://www.transparencymarketresearch.com/cryptococcosismarket.html
The global cryptococcosis market was valued at US$4.12 bn in 2015 and
is projected to reach US$6.27 bn by 2024, after expanding at a CAGR of
4.8% from 2016 to 2024.
One of the key factors driving the global cryptococcosis market is the
increasing incidence of cryptococcosis infections across the world. The
number of patients suffering from cryptococcosis has been found to be
on the rise at a faster rate than previously thought. The patients suffering
from the fungal infection are found to be in high numbers among HIV
positive patients. Consequently, the growing number of HIV patients is
also spurring the demand for advanced and effective treatment for the
disease.
Rising initiatives by government and non-government organizations is
also putting the pipeline development in the global cryptococcosis
market on the fast track in many countries, especially in developed ones.
However, the global cryptococcosis market is currently being affected
by restraining factors such as the increased mortality among
cryptococcosis infected patients, which reduces the overall scope of

testing and diagnostics, and the imminent patent expiry of key drugs
which will result in the large scale entry of cheaper generics.
The global cryptococcosis market is segmented into the key regions of
North America, Europe, Asia Pacific, Latin America, and the Middle
East and Africa. North America accounted for the leading share on the
global cryptococcosis market for 2015, due to the rising prevalence of
the infection in endemic areas of the U.S., coupled with a higher
penetration of healthcare services across the country.
The region is projected to continue to dominate the global
cryptococcosis market till 2024, a fact attributed to the rising numbers of
the HIV infected population in the region, a highly structured and
advanced healthcare industry, and well-defined reimbursement policies
from public as well as private health insurance firms.
The cryptococcosis market in the Middle East and Africa is projected to
expand at a substantial growth rate owing to the contribution of Sub-
Sahara African countries in terms of demand, where the count of HIV
patients is exceptionally high. North America and the Middle East and
Africa are projected to be highly lucrative regions in the global
cryptococcosis market, while Europe, Asia Pacific, and Latin America
expected to remain relatively smaller in terms of demand and growth
rate.

Based on the distribution channel, the global cryptococcosis market is
segmented into hospital pharmacies, retail pharmacies, drug store, and
mail order pharmacies. Retail pharmacy was the leading segment in the
global market on the basis of revenue, for 2015. This segment is also
expected to continue dominating the market till 2024, owing to the
growing contribution of long-term medication needed for successful
cryptococcosis treatment.
Online purchase of drugs has been highly popular in a lot of developed
economies, including the U.S. and Japan. Online pharmaceutical
retailers are also generating a high volume of preference in in emerging
economies such as Brazil, China, and India as well, further increasing
the scope of growth for the global cryptococcosis market over the
coming years.
The global cryptococcosis market is segmented on the basis of
treatment, primarily into Amphotericin B, Flucytosine and Fluconazole.
Amphotericin B further segmented into Amphocin, Fungizone, and other
products. Flucytosine is further segmented into Ancobon and other
products. Fluconazole includes Diflucan and other products. In terms of
treatment, Flucytosine was the leading segment in the global
cryptococcosis market in terms of revenue for 2015, driven by its large
scale adoption in the U.S.
The leading players in the global cryptococcosis market so far, have
included Bristol-Myers Squibb Company, Janssen Biotech, Inc.
(Johnson & Johnson), Abbott Laboratories, Novartis AG, Pfizer, Inc.,
Valeant Pharmaceuticals, Inc., Glenmark Pharmaceuticals and
Sigmapharm Laboratories LLC.

Browse Full Press Release on Cryptococcosis Market:
Press Release
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The
company’s exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants use
proprietary data sources and various tools and techniques to gather and
analyze information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research material
for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com